108 related articles for article (PubMed ID: 18683837)
1. Selective chemical rescue of a thyroid-hormone-receptor mutant, TRbeta(H435Y), identified in pituitary carcinoma and resistance to thyroid hormone.
Hassan AQ; Koh JT
Angew Chem Int Ed Engl; 2008; 47(38):7280-3. PubMed ID: 18683837
[No Abstract] [Full Text] [Related]
2. Analysis of the roles of mutations in thyroid hormone receptor-β by a bacterial biosensor system.
Shi C; Meng Q; Wood DW
J Mol Endocrinol; 2014 Feb; 52(1):55-66. PubMed ID: 24174637
[TBL] [Abstract][Full Text] [Related]
3. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
4. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone.
Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT
Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888
[TBL] [Abstract][Full Text] [Related]
5. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
6. The oligomeric state of thyroid receptor regulates hormone binding kinetics.
Cunha Lima ST; Rodrigues ED
J Endocrinol; 2011 Jul; 210(1):125-34. PubMed ID: 21508093
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
[TBL] [Abstract][Full Text] [Related]
8. Novel oncogenic actions of TRbeta mutants in tumorigenesis.
Guigon CJ; Cheng SY
IUBMB Life; 2009 May; 61(5):528-36. PubMed ID: 19391168
[TBL] [Abstract][Full Text] [Related]
9. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
Park JW; Zhao L; Willingham MC; Cheng SY
Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor.
Ando S; Sarlis NJ; Oldfield EH; Yen PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5572-6. PubMed ID: 11701737
[TBL] [Abstract][Full Text] [Related]
11. A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).
Teng X; Jin T; Brent GA; Wu A; Teng W; Shan Z
J Clin Endocrinol Metab; 2015 Jul; 100(7):2511-4. PubMed ID: 25867808
[TBL] [Abstract][Full Text] [Related]
12. A Novel Thyroid Hormone Receptor Beta Gene Mutation (G251V) in a Thai Patient with Resistance to Thyroid Hormone Coexisting with Pituitary Incidentaloma.
Sriphrapradang C; Srichomkwun P; Refetoff S; Mamanasiri S
Thyroid; 2016 Dec; 26(12):1804-1806. PubMed ID: 27758132
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor.
Malm J; Grover GJ; Färnegårdh M
Mini Rev Med Chem; 2007 Jan; 7(1):79-86. PubMed ID: 17266640
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury.
Milanesi A; Lee JW; Kim NH; Liu YY; Yang A; Sedrakyan S; Kahng A; Cervantes V; Tripuraneni N; Cheng SY; Perin L; Brent GA
Endocrinology; 2016 Jan; 157(1):4-15. PubMed ID: 26451739
[TBL] [Abstract][Full Text] [Related]
15. "They have ears but do not hear" (Psalms 135:17): non-thyroid hormone receptor beta (non-TRbeta) resistance to thyroid hormone.
Weiss RE
Thyroid; 2008 Jan; 18(1):3-5. PubMed ID: 18302513
[No Abstract] [Full Text] [Related]
16. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
17. A novel point mutation in cluster 3 of the thyroid hormone receptor beta gene (P247L) causing mild resistance to thyroid hormone.
Pohlenz J; Manders L; Sadow PM; Kansal PC; Refetoff S; Weiss RE
Thyroid; 1999 Dec; 9(12):1195-203. PubMed ID: 10646658
[TBL] [Abstract][Full Text] [Related]
18. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
[TBL] [Abstract][Full Text] [Related]
19. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
[TBL] [Abstract][Full Text] [Related]
20. The Affinity of Brominated Phenolic Compounds for Human and Zebrafish Thyroid Receptor β: Influence of Chemical Structure.
Kollitz EM; De Carbonnel L; Stapleton HM; Lee Ferguson P
Toxicol Sci; 2018 May; 163(1):226-239. PubMed ID: 29409039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
